Bennett Associates Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Bennett Associates Wealth Management's AMGN Position: Q1 2026 in Review
Bennett Associates Wealth Management reduced its Amgen (AMGN) stake by 8.5% in Q1 2026, selling an estimated $49.2K and leaving 1,479 shares worth $520K. The position accounts for 0.35% of the portfolio, ranked #31.
Bennett Associates Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 9 quarters since. The position peaked at $529K in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Bennett Associates Wealth Management held 1,479 shares of Amgen worth $520K as of Q1 2026.
- Bennett Associates Wealth Management sold 138 Amgen shares in Q1 2026, an estimated $49.2K.
- Amgen made up 0.35% of Bennett Associates Wealth Management's portfolio in Q1 2026, its #31 holding.
- Bennett Associates Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 9 quarters since.
- Bennett Associates Wealth Management's Amgen position peaked at $529K in Q4 2025.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Bennett Associates Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.